Wilfried Schroyens

4.3k total citations
94 papers, 1.8k citations indexed

About

Wilfried Schroyens is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Wilfried Schroyens has authored 94 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Hematology, 26 papers in Genetics and 20 papers in Oncology. Recurrent topics in Wilfried Schroyens's work include Platelet Disorders and Treatments (24 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (18 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (11 papers). Wilfried Schroyens is often cited by papers focused on Platelet Disorders and Treatments (24 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (18 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (11 papers). Wilfried Schroyens collaborates with scholars based in Belgium, Netherlands and United Kingdom. Wilfried Schroyens's co-authors include Zwi Berneman, Jan Michiels, Marc van der Planken, Alain Gadisseur, Huub H.D.M. van Vliet, Ulrich Budde, Hendrik De Raeve, Dirk Van Bockstaele, Ann Van de Velde and Guido Finazzi and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Wilfried Schroyens

92 papers receiving 1.7k citations

Peers

Countries citing papers authored by Wilfried Schroyens

Since Specialization

Citations

This map shows the geographic impact of Wilfried Schroyens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilfried Schroyens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilfried Schroyens more than expected).

Fields of papers citing papers by Wilfried Schroyens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilfried Schroyens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilfried Schroyens. The network helps show where Wilfried Schroyens may publish in the future.

Co-authorship network of co-authors of Wilfried Schroyens

This figure shows the co-authorship network connecting the top 25 collaborators of Wilfried Schroyens. A scholar is included among the top collaborators of Wilfried Schroyens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wilfried Schroyens. Wilfried Schroyens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The TEMPI Syndrome: A Monoclonal Gammopathy of Clinical Significance Driving Erythropoietin Production 2024 ·Blood ·David B. Sykes, (unknown), Tysheena P. Charles, Jens Wrammert, Wilfried Schroyens	0
2	Evidence-Based Novel Management Options of Acute Deep Vein Thrombosis (DVT) and Prevention of DVT Recurrence in Primary Care Medicine Anno 2018 - 2020 2020 ·Acta Scientific Medical Sciences ·Jan Michiels, (unknown), Rob Strijkers, (unknown), (unknown), (unknown), Wilfried Schroyens, Alain Gadisseur	0
3	Comparison of the Power of Procalcitonin and C-Reactive Protein to Differentiate between Different Etiologies of Febrile Neutropenia in Patients with Prolonged Profound Neutropenia 2017 ·Blood ·Anke Verlinden, Véronique De Vroey, Ella Roelant, (unknown), Zwi Berneman, Wilfried Schroyens, Alain Gadisseur	1
4	Adult acute precursor B-cell lymphoblastic leukemia presenting as hypercalcemia and osteolytic bone lesions 2017 ·Experimental Hematology and Oncology ·(unknown), Zwi Berneman, Wilfried Schroyens, (unknown), Anke Verlinden, Alain Gadisseur	7
5	Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party 2015 ·Bone Marrow Transplantation ·Stephen Robinson, Ariane Boumendil, Hervé Finel, Didier Blaise, Xavier Poiré, Emmanuelle Nicolas‐Virelizier, Reuven Or, Ram Malladi, (unknown), Luc Matthieu Fornecker, Dolores Caballero, David Pohlreich, A. Nagler, Catherine Thiéblemont, Jürgen Finke, Emmanuel Bachy, Laure Vincent, Wilfried Schroyens, H Schouten, Peter Dreger	34
6	BHS guidelines for the treatment of marginal zone lymphomas 2014 ·Open Repository and Bibliography (University of Liège) ·Dominique Bron, Éric Van Den Neste, Alain Kentos, Fritz Offner, Wilfried Schroyens, Christophe Bonnet, Ambro van Hoof, G. Verhoef, Ann Janssens	2
7	Changing Concepts of Diagnostic Criteria of Myeloproliferative Disorders and the Molecular Etiology and Classification of Myeloproliferative Neoplasms: From Dameshek 1950 to Vainchenker 2005 and Beyond 2014 ·Acta Haematologica ·Jan Michiels, Zwi Berneman, Wilfried Schroyens, Hendrik De Raeve	33
8	Bone marrow findings of the newly described TEMPI syndrome: when erythrocytosis and plasma cell dyscrasia coexist 2014 ·Modern Pathology ·Flavia Rosado, Jennifer L. Oliveira, (unknown), Wilfried Schroyens, David B. Sykes, Saad S. Kenderian, Martha Q. Lacy, Robert A. Kyle, James D. Hoyer	22
9	Guidelines for newly diagnosed diffuse large B-cell lymphoma (DLBCL) and relapsed DLBCL 2013 ·Open Repository and Bibliography (University of Liège) ·G. Verhoef, Wilfried Schroyens, Dominique Bron, Christophe Bonnet, Virginie De Wilde, Ambro van Hoof, Ann Janssens, Daan Dierickx, Marc André, Éric Van Den Neste	2
10	Early-Childhood Membranous Nephropathy Due to Cationic Bovine Serum Albumin 2011 ·New England Journal of Medicine ·David B. Sykes, Wilfried Schroyens, Casey L. O’Connell	1
11	Laboratory Diagnosis and Molecular Basis of Mild von Willebrand Disease Type 1 2009 ·Acta Haematologica ·Jan Michiels, Zwi Berneman, Alain Gadisseur, Marc van der Planken, Wilfried Schroyens, Huub H.D.M. van Vliet	9
12	Laboratory Diagnosis and Molecular Classification of von Willebrand Disease 2009 ·Acta Haematologica ·Alain Gadisseur, Cédric Hermans, Zwi Berneman, Wilfried Schroyens, Hans Deckmyn, Jan Michiels	32
13	Laboratory and Molecular Characteristics of Recessive von Willebrand Disease Type 2C (2A Subtype IIC) of Variable Severity due to Homozygous or Double Heterozygous Mutations in the D1 and D2 Domains 2009 ·Acta Haematologica ·Jan Michiels, Alain Gadisseur, Marc van der Planken, Wilfried Schroyens, Zwi Berneman	3
14	Immune-Mediated Etiology of Acquired von Willebrand Syndrome in Systemic Lupus Erythematosus and in Benign Monoclonal Gammopathy: Therapeutic Implications 2006 ·Seminars in Thrombosis and Hemostasis ·Jan Michiels, Zwi Berneman, Alain Gadisseur, Marc van der Planken, Wilfried Schroyens, Ulrich Budde, (unknown)	24
15	The Paradox of Platelet Activation and Impaired Function: Platelet-von Willebrand Factor Interactions, and the Etiology of Thrombotic and Hemorrhagic Manifestations in Essential Thrombocythemia and Polycythemia Vera 2006 ·Seminars in Thrombosis and Hemostasis ·Jan Michiels, Zwi Berneman, Wilfried Schroyens, Guido Finazzi, Ulrich Budde, (unknown)	105
16	Characterization, Classification, and Treatment of von Willebrand Diseases: A Critical Appraisal of the Literature and Personal Experiences 2005 ·Seminars in Thrombosis and Hemostasis ·Jan Michiels, Alain Gadisseur, Ulrich Budde, Zwi Berneman, Marc van der Planken, Wilfried Schroyens, Ann Van de Velde, (unknown)	26
17	Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII–von Willebrand factor concentrate (Haemate-P) 2004 ·Blood Coagulation & Fibrinolysis ·Jan Michiels, Zwi Berneman, Marc van der Planken, Wilfried Schroyens, Ulrich Budde, (unknown)	27
18	Bilateral adrenal swelling as a cause of chest, back, and upper abdominal pain in essential thrombocythemia and polycythemia vera is due to microvascular ischemic thrombosis rather than to hemorrhage 2002 ·Annals of Hematology ·Jan Michiels, Zwi Berneman, Wilfried Schroyens, Gabriël P. Krestin	16
19	Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients 1998 ·Leukemia ·Jeroen Mebis, Herman Goossens, (unknown), (unknown), (unknown), Jan Van Droogenbroeck, Wilfried Schroyens, Zwi Berneman	36
20	Comparative effect of cisplatin, spiroplatin, carboplatin and iproplatin in a human tumor clonogenic assay 1990 ·Journal of Cancer Research and Clinical Oncology ·Wilfried Schroyens, P. Dodion, Marcel Rozencweig	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact